• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Iranian Journal of Pharmaceutical Research
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 18 (2019)
Volume Volume 17 (2018)
Volume Volume 16 (2017)
Volume Volume 15 (2016)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Special Issue
Issue Issue 1
Volume Volume 14 (2015)
Volume Volume 13 (2014)
Volume Volume 12 (2013)
Volume Volume 11 (2012)
Volume Volume 10 (2011)
Volume Volume 9 (2010)
Volume Volume 8 (2009)
Volume Volume 7 (2008)
Volume Volume 6 (2007)
Volume Volume 5 (2006)
Volume Volume 4 (2005)
Volume Volume 3 (2004)
Volume Volume 2 (2003)
Volume Volume 1 (2002)
(2016). Antiviral Profile of Brown and Red Seaweed Polysaccharides Against Hepatitis C Virus. Iranian Journal of Pharmaceutical Research, 15(3), 483-491. doi: 10.22037/ijpr.2016.1944
. "Antiviral Profile of Brown and Red Seaweed Polysaccharides Against Hepatitis C Virus". Iranian Journal of Pharmaceutical Research, 15, 3, 2016, 483-491. doi: 10.22037/ijpr.2016.1944
(2016). 'Antiviral Profile of Brown and Red Seaweed Polysaccharides Against Hepatitis C Virus', Iranian Journal of Pharmaceutical Research, 15(3), pp. 483-491. doi: 10.22037/ijpr.2016.1944
Antiviral Profile of Brown and Red Seaweed Polysaccharides Against Hepatitis C Virus. Iranian Journal of Pharmaceutical Research, 2016; 15(3): 483-491. doi: 10.22037/ijpr.2016.1944

Antiviral Profile of Brown and Red Seaweed Polysaccharides Against Hepatitis C Virus

Article 296, Volume 15, Issue 3, Summer 2016, Page 483-491  XML PDF (993.65 K)
Document Type: Research article
DOI: 10.22037/ijpr.2016.1944
Abstract
Hepatitis C virus (HCV) has infected 3% of the population worldwide and 20% of the population in Egypt. HCV infection can lead to hepatocellular carcinoma and death. The presently available treatment with interferon plus ribavirin, has limited benefits due to adverse side effects. Seaweeds have become a major source of new compounds to treat viral diseases. This work aimed to study the effect of four species of seaweeds as anti- HCV. The inhibition of lipid peroxidation was measured by evaluating the ability of seaweed extracts to scavenge the free radicals. The HepG2 cells were infected with the HCV and treated with each seaweed polysaccharide. Inhibition of viral replication was detected using the Real Time PCR (RT) qPCR. To explain the mode of the seaweed action on HCV, three modes of virus infections and seaweed polysaccharide treatments were applied. All treatments had the ability to inhibit the HCV with priority to Laurencia obtusa (82.36%), while the potentiality to scavenge the free radicals reached up to 81.5 % with the Sargassum vulgare. Seaweed polysaccharide extracts may be helpful in exploring further gateways for antiviral therapy against HCV.
Keywords
seaweeds; Polysaccharides; hepatitis C virus; free radicals; PCR
Main Subjects
Pharmacutical biotechnology
Statistics
Article View: 2,129
PDF Download: 37,788
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Statistics

Journal Management System. Designed by sinaweb.